Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Genmab to test daratumumab in combination with carfilzomib and dexamethasone in MM patients

Nov. 11, 2016

Celsion reports positive data for OVATION phase Ib trial

Nov. 11, 2016

FDA grants BTD to Seattle Genetics' brentuximab vedotin

Nov. 11, 2016

FDA approves Opdivo for head and neck cancer

Nov. 11, 2016

FDA removes partial clinical hold on NY-ESO SPEAR study

Nov. 11, 2016

Bristol-Myers Squibb and Infinity Pharmaceuticals sign collaboration

Nov. 10, 2016

Imugene initiates phase Ib/II study of HER-Vaxx in gastric cancer

Nov. 10, 2016

Cell Medica and Baylor to develop off-the-shelf allogeneic cell therapy for cancer

Nov. 10, 2016

5T4 oncofetal antigen as a promising target for immune intervention in cancer

Nov. 9, 2016

DNAtrix in license agreement with University of Florida to develop novel oncolytic virus platform

Nov. 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026